Verrica Pharmaceuticals (VRCA) Stock Chart & Stock Price History → Does this make you sick? (From Allegiance Gold) (Ad) Free VRCA Stock Alerts $8.40 -0.27 (-3.11%) (As of 08:37 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Verrica Pharmaceuticals Stock Price Performance5 Day Performance-7.69%1 Month Performance+20.34%3 Month Performance+61.85%6 Month Performance+126.42%Year-To-Date Performance+14.75%1 Year Performance+41.41% Receive VRCA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit VRCA Stock Chart for Monday, May, 20, 2024 VRCA Chart by TradingView Verrica Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$9.15$8.67-5.25%$9.28$8.64162,715 shs$367.78 million05/16/2024$9.10$9.15+0.55%$9.66$8.85177,268 shs$388.14 million05/15/2024$9.49$9.10-4.11%$9.95$8.91269,062 shs$386.02 million05/14/2024$9.56$9.49-0.73%$11.40$9.30901,750 shs$402.57 million05/13/2024$8.00$9.56+19.50%$9.61$7.84562,124 shs$405.54 million05/10/2024$7.84$8.00+2.04%$8.17$7.51525,106 shs$339.36 million Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$7.61$7.84+3.02%$7.95$7.54106,916 shs$332.57 million05/08/2024$7.65$7.61-0.52%$7.75$7.5286,420 shs$322.82 million05/07/2024$7.31$7.65+4.65%$7.79$7.21347,559 shs$324.51 million05/06/2024$7.26$7.31+0.69%$7.36$7.14240,979 shs$310.09 million05/03/2024$6.76$7.26+7.40%$7.31$6.71301,095 shs$307.97 million05/02/2024$6.85$6.76-1.31%$6.97$6.54188,130 shs$286.76 million05/01/2024$6.97$6.85-1.65%$7.04$6.79177,091 shs$290.58 million04/30/2024$7.15$6.97-2.59%$7.12$6.71245,716 shs$295.46 million04/29/2024$6.87$7.15+4.08%$7.58$6.85373,313 shs$303.30 million04/26/2024$6.65$6.87+3.31%$6.90$6.62111,046 shs$291.43 million04/25/2024$6.79$6.65-2.06%$6.95$6.60297,436 shs$282.09 million04/24/2024$6.85$6.79-0.88%$6.86$6.66114,880 shs$288.03 million04/23/2024$6.79$6.85+0.88%$6.94$6.7886,259 shs$290.58 million04/22/2024$6.98$6.79-2.72%$7.00$6.57311,343 shs$288.03 million04/19/2024$6.90$6.98+1.16%$7.01$6.78125,729 shs$296.09 million04/18/2024$7.06$6.90-2.27%$7.06$6.80202,527 shs$292.70 million04/17/2024$7.00$7.06+0.86%$7.14$6.93105,357 shs$299.49 million04/16/2024$6.92$7.00+1.16%$7.15$6.8489,815 shs$296.94 million04/15/2024$6.87$6.92+0.73%$6.96$6.77163,629 shs$293.54 million04/12/2024$7.07$6.87-2.83%$7.17$6.75184,161 shs$291.43 million04/11/2024$7.19$7.07-1.67%$7.20$6.89123,880 shs$299.90 million04/10/2024$7.05$7.19+1.99%$7.31$6.91192,521 shs$305 million04/09/2024$7.00$7.05+0.71%$7.30$6.9195,216 shs$299.06 million04/08/2024$6.73$7.00+4.01%$7.03$6.45196,771 shs$296.94 million04/05/2024$6.42$6.73+4.83%$6.76$6.36480,497 shs$285.49 million04/04/2024$6.16$6.42+4.22%$6.72$6.20414,477 shs$272.34 million04/03/2024$5.89$6.16+4.58%$6.19$5.79106,959 shs$261.31 million04/02/2024$5.92$5.89-0.51%$5.95$5.60136,717 shs$249.85 million04/01/2024$5.92$5.92$6.03$5.5867,978 shs$251.12 million03/29/2024$5.92$5.92$6.03$5.6092,024 shs$251.13 million03/28/2024$5.65$5.92+4.78%$6.01$5.6088,474 shs$251.13 million03/27/2024$5.32$5.65+6.20%$5.80$5.30210,551 shs$239.67 million03/26/2024$5.06$5.32+5.14%$5.47$4.78404,153 shs$225.67 million03/25/2024$5.01$5.06+1.00%$5.17$4.91246,107 shs$214.65 millionDoes this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit03/22/2024$5.05$5.01-0.79%$5.09$4.8867,363 shs$212.52 million03/21/2024$4.96$5.05+1.81%$5.09$4.8976,985 shs$214.22 million03/20/2024$4.74$4.96+4.64%$4.98$4.6058,747 shs$210.40 million03/19/2024$4.75$4.74-0.21%$4.80$4.7154,834 shs$201.07 million03/18/2024$4.80$4.75-1.04%$4.82$4.6091,030 shs$201.50 million03/15/2024$4.90$4.80-2.04%$4.93$4.69109,273 shs$203.62 million03/14/2024$5.16$4.90-5.04%$5.14$4.82121,266 shs$207.86 million03/13/2024$5.20$5.16-0.77%$5.29$4.96147,108 shs$218.89 million03/12/2024$5.21$5.20-0.19%$5.33$5.0370,190 shs$220.58 million03/11/2024$5.01$5.21+3.99%$5.27$4.91106,001 shs$221.01 million03/08/2024$4.86$5.01+3.09%$5.08$4.8872,850 shs$212.52 million03/07/2024$4.97$4.86-2.21%$5.09$4.8557,234 shs$206.16 million03/06/2024$5.14$4.97-3.31%$5.30$4.89103,986 shs$210.83 million03/05/2024$5.55$5.14-7.39%$5.59$5.12101,605 shs$218.04 million03/04/2024$5.55$5.55$5.61$5.4182,860 shs$235.43 million03/01/2024$5.27$5.55+5.31%$5.73$5.21179,555 shs$233.43 million02/29/2024$5.72$5.27-7.87%$6.05$5.27243,612 shs$221.66 million02/28/2024$5.67$5.72+0.88%$5.79$5.54144,922 shs$240.58 million02/27/2024$5.40$5.67+5.00%$5.82$5.45187,220 shs$238.48 million02/26/2024$5.18$5.40+4.25%$5.50$4.99119,855 shs$227.12 million02/23/2024$5.11$5.18+1.37%$5.30$5.0067,587 shs$217.87 million02/22/2024$4.99$5.11+2.40%$5.12$4.76176,200 shs$214.93 million02/21/2024$5.19$4.99-3.85%$5.32$4.9285,298 shs$209.88 million02/20/2024$5.45$5.19-4.77%$5.37$5.1468,598 shs$218.29 million02/19/2024$5.45$5.45+0.09%$5.63$5.4274,600 shs$229.23 million Related Companies: STTK Stock Price Chart KRRO Stock Price Chart NGNE Stock Price Chart ESPR Stock Price Chart MREO Stock Price Chart TERN Stock Price Chart HRTX Stock Price Chart ANRO Stock Price Chart ORGO Stock Price Chart AMRN Stock Price Chart Receive VRCA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRCA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldUrgent Nvidia WarningAltimetryDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.